Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up
- 31 December 2001
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 95 (12) , 992-998
- https://doi.org/10.1053/rmed.2001.1185
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The health economics of asthma and rhinitis. I. Assessing the economic impactJournal of Allergy and Clinical Immunology, 2001
- Low-Dose Inhaled Corticosteroids and the Prevention of Death from AsthmaNew England Journal of Medicine, 2000
- Decrease in asthma mortality rate in Israel from 1991-1995: Is it related to increased use of inhaled corticosteroids?Journal of Allergy and Clinical Immunology, 2000
- Fluticasone Alone or in Combination With Salmeterol vs Triamcinolone in AsthmaChest, 1999
- A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthmaJournal of Allergy and Clinical Immunology, 1999
- Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasoneEuropean Respiratory Journal, 1999
- Safety and Efficacy of Fluticasone and Beclomethasone in Moderate to Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthmaJournal of Allergy and Clinical Immunology, 1997
- Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in the prevalence of asthmaJournal of Allergy and Clinical Immunology, 1996
- Use of a pharmacy and medical claims database to document cost centers for 1993 annual asthma expendituresArchives of Family Medicine, 1996